Calvin C. Wu

538 total citations
11 papers, 354 citations indexed

About

Calvin C. Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology. According to data from OpenAlex, Calvin C. Wu has authored 11 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in Calvin C. Wu's work include Diabetes Treatment and Management (4 papers), Pharmacology and Obesity Treatment (3 papers) and Parasites and Host Interactions (3 papers). Calvin C. Wu is often cited by papers focused on Diabetes Treatment and Management (4 papers), Pharmacology and Obesity Treatment (3 papers) and Parasites and Host Interactions (3 papers). Calvin C. Wu collaborates with scholars based in United States, China and Canada. Calvin C. Wu's co-authors include Weston P. Miller, Michael J. Econs, Leanne M. Ward, Lynda E. Polgreen, Linda A. DiMeglio, Paul J. Orchard, Dolores Shoback, Anna Petryk, Karl Insogna and Eric T. Rush and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of Surgery and European Journal of Immunology.

In The Last Decade

Calvin C. Wu

10 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Calvin C. Wu United States 7 130 97 82 68 63 11 354
Ana L.C. Martinelli Brazil 14 34 0.3× 55 0.6× 156 1.9× 19 0.3× 15 0.2× 26 544
Martha Pérez‐Rodríguez Mexico 18 111 0.9× 32 0.3× 176 2.1× 23 0.3× 42 0.7× 35 672
F. Amri Tunisia 14 84 0.6× 75 0.8× 41 0.5× 43 0.6× 20 0.3× 34 482
Wasif M. Abidi United States 13 124 1.0× 9 0.1× 281 3.4× 82 1.2× 134 2.1× 46 619
Edgar Duque Colombia 7 41 0.3× 54 0.6× 539 6.6× 86 1.3× 138 2.2× 7 766
Russell Thomson United States 11 116 0.9× 20 0.2× 31 0.4× 44 0.6× 8 0.1× 13 518
Refaat Kamel Egypt 11 79 0.6× 87 0.9× 110 1.3× 4 0.1× 25 0.4× 28 500
Swagata Ghosh United States 9 64 0.5× 37 0.4× 39 0.5× 4 0.1× 21 0.3× 14 335
Yanfen Yang United States 11 58 0.4× 106 1.1× 160 2.0× 3 0.0× 26 0.4× 23 504
Efrat G. Saar Israel 8 211 1.6× 11 0.1× 14 0.2× 11 0.2× 66 1.0× 14 426

Countries citing papers authored by Calvin C. Wu

Since Specialization
Citations

This map shows the geographic impact of Calvin C. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin C. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin C. Wu more than expected).

Fields of papers citing papers by Calvin C. Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin C. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin C. Wu. The network helps show where Calvin C. Wu may publish in the future.

Co-authorship network of co-authors of Calvin C. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin C. Wu. A scholar is included among the top collaborators of Calvin C. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin C. Wu. Calvin C. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wu, Calvin C., et al.. (2025). Less frequent dosing of GLP‐1 receptor agonists as a viable weight maintenance strategy. Obesity. 33(7). 1232–1236.
2.
Wu, Calvin C., et al.. (2025). Incretin mimetics for weight loss forgive nonadherence. Diabetes Obesity and Metabolism. 27(8). 4109–4117. 1 indexed citations
3.
Wu, Calvin C., et al.. (2025). Alternative dosing regimens of GLP ‐1 receptor agonists may reduce costs and maintain weight loss efficacy. Diabetes Obesity and Metabolism. 27(4). 2251–2258. 6 indexed citations
4.
Reddy, Sushma, et al.. (2023). Personalized Virtual Care Using Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Less Intensive Therapies. Clinical Diabetes. 41(3). 452–457. 3 indexed citations
6.
Wu, Calvin C., Michael J. Econs, Linda A. DiMeglio, et al.. (2017). Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group. The Journal of Clinical Endocrinology & Metabolism. 102(9). 3111–3123. 138 indexed citations
7.
Wen, Xiaoyun, Lei He, Ying Chi, et al.. (2011). Dynamics of Th17 Cells and Their Role in Schistosoma japonicum Infection in C57BL/6 Mice. PLoS neglected tropical diseases. 5(11). e1399–e1399. 69 indexed citations
8.
Ayazi, Shahin, Anand P. Tamhankar, Steven R. DeMeester, et al.. (2010). The Impact of Gastric Distension on the Lower Esophageal Sphincter and Its Exposure to Acid Gastric Juice. Annals of Surgery. 252(1). 57–62. 42 indexed citations
9.
Wang, Xuefeng, Ying Chi, Jason S. Hoellwarth, et al.. (2010). The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy. Parasites & Vectors. 3(1). 109–109. 11 indexed citations
10.
Ayazi, Shahin, Jeffrey A. Hagen, Joerg Zehetner, et al.. (2009). The Value of High-Resolution Manometry in the Assessment of the Resting Characteristics of the Lower Esophageal Sphincter. Journal of Gastrointestinal Surgery. 13(12). 2113–2120. 27 indexed citations
11.
Wang, Xuefeng, Zhou Sha, Ying Chi, et al.. (2009). CD4+CD25+ Treg induction by an HSP60‐derived peptide SJMHE1 from Schistosoma japonicum is TLR2 dependent. European Journal of Immunology. 39(11). 3052–3065. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026